Yes, there are several pharmaceutical ETFs available. Here are a few examples:
- Invesco Pharmaceuticals ETF (PJP): This ETF was launched on June 23, 2005, and is designed to offer broad exposure to the Healthcare-Pharma segment of the equity market1. It has an annual operating expense of 0.57% and a 12-month trailing dividend yield of 0.89%.
- iShares U.S. Pharmaceuticals ETF (IHE): Launched on May 1, 2006, this ETF seeks to track the investment results of an index composed of U.S. equities in the pharmaceuticals sector2. It has a net asset of $660,316,529 and a daily volume of 203,272.
- VanEck Pharmaceutical ETF (PPH): This ETF holds shares of companies involved in the research, development, manufacture, sale, or distribution of pharmaceuticals and drugs of all types3. It has a market capitalization of $657.28 million and a PE ratio of 21.04.
These ETFs provide investors with exposure to the pharmaceutical sector, offering diversification and potential growth opportunities. The expense ratios for these ETFs vary, with PJP having the lowest at 0.57%, followed by IHE at 0.19%, and PPH at an undisclosed rate. It's important to consider the expense ratio when selecting an ETF, as it can impact the overall performance of the fund.